Position in PFE
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$1,770,987
-$294,184 QoQ
Shares Held
73,546
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,013
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archer Investment Corp holds $22,689,953 across 14 Drug Manufacturers - General names. PFE ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,262 | $9,909,691 | |
| 2 | JNJ |
Johnson & Johnson
|
15,648 | $3,974,122 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,453 | $2,756,710 | |
| 4 | PFE |
Pfizer Inc
This page
|
73,546 | $1,770,987 | |
| 5 | ABBV |
AbbVie Inc.
|
6,483 | $1,631,382 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,272 | $1,398,552 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,578 | $957,404 | |
| 8 | SNY |
Sanofi
|
4,072 | $173,711 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,770,987 | 73,546 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $2,065,171 | 73,546 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,828,805 | 73,446 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,724,282 | 67,672 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,197,237 | 49,391 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $718,211 | 28,343 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $776,984 | 29,287 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,809,299 | 62,519 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,930,703 | 69,003 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,803,500 | 64,991 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,625,713 | 56,468 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,727,095 | 52,068 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,779,456 | 48,513 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,812,744 | 44,430 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,276,593 | 44,430 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,890,738 | 43,207 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,236,506 | 42,657 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,131,319 | 41,169 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,379,242 | 40,292 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,725,819 | 40,126 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,456,752 | 37,200 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,495,936 | 41,290 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,721,272 | 46,761 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,527,158 | 41,612 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,237,303 | 37,838 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,232,941 | 37,774 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||